-
Technical Articles
- API Heterogeneity in a Multilayered Transdermal Patch
- Biphasic Vesicles: A Novel, Lipid-Based, Dermal Delivery System for Large-Molecule Drugs
- Challenges in Formulating Adhesives for Transdermal Drug Delivery
- Dermal Electroporation: An Efficient and Tolerable Method of Delivering DNA Vaccines
- Early Stage Technologies for Dermal and Transdermal Drug Delivery: Magnetophoresis and Electret
- Immunization Through the Skin
- Joining the Transdermal Pipeline
- Nanocarriers for Intradermal Delivery of Pharmaceuticals and Cosmeceuticals
- On the Transdermal Formulation of Peptide and Protein Drugs
- Passive Transdermal Drug Delivery Systems (TDDS): Challenges and Potential
- Patchless Transdermal Drug Delivery (TDD)
- Profiles of Recently Approved Transdermal Drug Delivery Systems (TDDS), Part 1: Exelon Patch - Example of Life Cycle Strategy for Successful Products; Generic Clonidine Transdermal Systems - Design and Delivery Attributes
- Profiles of Recently Approved Transdermal Drug Delivery Systems (TDDS), Part 2: Exelon Patch — Example of Life Cycle Strategy for Successful Products; Generic Clonidine Transdermal Systems — Design and Delivery Attributes
- Prototype Testing
- Selection of Active Pharmaceutical Ingredients (APIs) and Excipients for Topical Formulations
- Transdermal Pharmaceuticals: Unique Aspects of Clinical Development
-
Webinars
Transdermal is the only technical publication devoted exclusively to readers involved in development and production of pharmaceuticals delivered through the skin.
